Chapter

RealManage Promotes Rachel Garrett to President of Walters Management

Retrieved on: 
火曜日, 5月 7, 2024
Organization, Executive, Chapter, Region, CCAM, CAI, Community Associations Institute, Management

San Diego, CA, May 07, 2024 (GLOBE NEWSWIRE) -- RealManage, a leading community association management company, is thrilled to announce the promotion of Rachel Garrett, PCAM®, AMS®, CCAM, to the role of President of Walters Management, a RealManage Family of Brands company.

Key Points: 
  • San Diego, CA, May 07, 2024 (GLOBE NEWSWIRE) -- RealManage, a leading community association management company, is thrilled to announce the promotion of Rachel Garrett, PCAM®, AMS®, CCAM, to the role of President of Walters Management, a RealManage Family of Brands company.
  • Since joining Walters Management as Regional Vice President for the South County market in January 2016, Rachel has consistently delivered outstanding results, maintaining over 96% client retention over the past eight years.
  • Her dedication to client satisfaction, coupled with her strategic fiscal management prowess, has been instrumental in shaping Walters Management's reputation for unparalleled service and success.
  • Rolando Coronado, the Executive Vice President of Operations for RealManage’s western markets, stated, “I’m excited to have Rachel leading our Walters Management operation as part of our RealManage Family of Brands.

APPALACHIAN MOUNTAIN CLUB'S CORMAN HARRIMAN OUTDOOR CENTER OPENS FOR 2024 SEASON

Retrieved on: 
月曜日, 5月 6, 2024
Water quality, Harriman State Park, Climate change, Nature, Chapter, University, Greater New York, Atmosphere, AMC, Swimming, Hotel

NEW YORK, May 6, 2024 /PRNewswire/ -- The Appalachian Mountain Club (AMC), America's oldest conservation and recreation organization, announced today that its famed Stephen & Betsy Corman AMC Harriman Outdoor Center in New York's Harriman State Park is open for the 2024 season.

Key Points: 
  • NEW YORK, May 6, 2024 /PRNewswire/ -- The Appalachian Mountain Club (AMC), America's oldest conservation and recreation organization, announced today that its famed Stephen & Betsy Corman AMC Harriman Outdoor Center in New York's Harriman State Park is open for the 2024 season.
  • "The Corman Harriman Outdoor Center is one of Greater New York City's hidden gems," said Nicole Zussman, President and CEO of the Appalachian Mountain Club.
  • Corman Harriman Outdoor Center often hosts group activities by AMC's Chapters , which are open to the public and available for every skill level.
  • AMC Guides are available to plan custom adventures for groups staying at Corman Harriman Outdoor Center.

Hematology Collaboration and Licensing Partnering Analysis Report 2024 with Directory of Deals Signed Since 2016 - ResearchAndMarkets.com

Retrieved on: 
金曜日, 5月 3, 2024
Biotechnology, Pharmaceutical, Health, Chapter Six, Directory, Chapter Three, Hyperlink, Chapter One, Chapter, Chapter Five, Orientation, Confidentiality, A-Z, Chapter Four, Intellectual property

Hematology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hematology deals entered into by the worlds leading biopharma companies.

Key Points: 
  • Hematology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hematology deals entered into by the worlds leading biopharma companies.
  • Fully revised and updated, the report provides details of hematology deals from 2016 to 2024.
  • Chapter 3 covers the financial deal terms for deals signed in the hematology field with stage of development announced.
  • Chapter 5 provides a comprehensive and detailed review of hematology deals signed and announced since 2016 where a contract document is available.

IIBA Empowers Future Business Analysis Professionals with New Student Membership

Retrieved on: 
火曜日, 4月 16, 2024
IIBA, AI, Chapter, Business analysis, Career development, Vocational school, Student, Organization, Knowledge, Nursing

TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- The International Institute of Business Analysis (IIBA) continues to advance the business analysis profession by introducing a new membership option for full-time university or college students.

Key Points: 
  • TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- The International Institute of Business Analysis (IIBA) continues to advance the business analysis profession by introducing a new membership option for full-time university or college students.
  • As business evolves, so do career opportunities for aspiring business analysis professionals.
  • Here’s a sample of the diverse range of business analysis roles in today’s workplace:
    “Our student membership offers early access to the profession for tomorrow’s business analysis professionals.
  • Advocacy and Representation: Collaborate with your local IIBA chapter to contribute to advocacy activities shaping the future of business analysis.

Infectious Diseases Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 1,726 Deals Signed Since 2019 - ResearchAndMarkets.com

Retrieved on: 
月曜日, 4月 29, 2024
Infectious Diseases, Biotechnology, Pharmaceutical, Health, Chapter Six, Directory, Chapter Three, Infection, Hyperlink, Chapter One, Chapter, Chapter Five, Orientation, A-Z, Chapter Four, Pharmaceutical industry

Infectious Diseases Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious diseases deals entered into by the world's leading biopharma companies.

Key Points: 
  • Infectious Diseases Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious diseases deals entered into by the world's leading biopharma companies.
  • Fully revised and updated, the report provides details of 1726 infectious disease deals from 2019 to 2024.
  • Chapter 5 provides a comprehensive and detailed review of infectious diseases deals signed and announced since 2019 where a contract document is available.
  • Infectious Diseases Collaboration and Licensing Deals includes:
    In Infectious Diseases Collaboration and Licensing Deals, the available deals are listed by:

Oncology Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 3685 Deals Signed Since 2019 - ResearchAndMarkets.com

Retrieved on: 
水曜日, 4月 24, 2024
Science, Other Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Other Health, Chapter Three, Hyperlink, Chapter One, Chapter Five, Orientation, Chapter Four, Chapter Six, A-Z, Directory, Chapter, Nursing

Oncology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the oncology deals entered into by the worlds leading biopharma companies.

Key Points: 
  • Oncology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the oncology deals entered into by the worlds leading biopharma companies.
  • Fully revised and updated, the report provides details of 3685 oncology deals from 2019 to 2024.
  • Chapter 5 provides a comprehensive and detailed review of oncology deals signed and announced since 2019 where a contract document is available.
  • Oncology Collaboration and Licensing Deals includes:
    In Oncology Collaboration and Licensing Deals, the available deals are listed by:

Monetary asmmetries without (and with) price stickiness

Retrieved on: 
金曜日, 4月 19, 2024
Online, University, Public Security Section 9, Employment, Calibration, Small, Equity, Volume Ten, Research Papers in Economics, Policy, A.4, Communication, Crisis, Mass, Silvana Tenreyro, Business, Shock, Intuition, Business cycle, TFP, Volume, European Economic Review, Marginal value, SME, NBER, Forecasting, Depression, 3rd millennium, European Economic Association, Conceptual model, Journal of Monetary Economics, Insurance, Harmonization, Great Depression, CES, Economic Inquiry, Paper, Environment, Political economy, Journal of Financial Economics, MIT, University of York, COVID-19, Behavior, Review of Economic Dynamics, Rigid transformation, Website, Access to finance, Accounting, Working paper, Probability, Total, Appendix, Section 8, Quarterly Journal of Economics, Zero lower bound, Curve, Chapter, Cost, Nominal, Journal of Political Economy, Euro, PDF, ECB, Unemployment, Hoarding, STAT, Economic Policy (journal), Household, Canadian International Council, Social science, Government, Federal Reserve Bank, JEL, Journal, Textbook, Missing, Food, Private sector, A.5, Asymmetric, The Journal of Finance, Credit, Speech, Princeton University Press, Literature, NK, European Central Bank, Growth, Labour, Monetary economics, Loss aversion, Financial intermediary, Injection, Elasticity, Inventory, Subprime lending, Ben Bernanke, Finance, BIS, Phillips curve, International Economic Review, Money, London School of Economics, Marginal product of labor, Pruning, Marginal product, The Economic Journal, Rate, Aswath Damodaran, Risk, OECD, Competition (economics), Section 4, MIT Press, Consumption, Bond, Section 3, Yield curve, Loanable funds, Habit, Cobb–Douglas production function, Economy, Aarhus University, Financial economics, Section 2, Conference, Central bank, Chapter Two, Monetary policy, Capital, Hartman–Grobman theorem, CEPR, Framework, American Economic Review, Capital Markets Union, ZLB, Exercise, Liquidity, Interest, Intensive word form, Workshop, European Commission, Macroeconomic Dynamics, Population growth, B1, Response, Quarterly Journal, Community business development corporation, GDP, E31, Control, Journal of Economic Theory, Christian Social Union (UK), T2M, Hamper, Data, American Economic Journal, Aggregate, Konstantinidis, B.1, A.9, A.6, Remuneration, Civil service commission, EUR, Uncertainty, Motivation, A.7, Bank, GFC, Section 13, Motion, Reproduction, IMF, Staggers Rail Act, Abstract, Tale, Handbook, Asymmetry, Stanford University, Communications satellite
Key Points: 

    IIBA Launches New Chapter Platform Supporting Global Community Engagement

    Retrieved on: 
    火曜日, 3月 26, 2024
    Business analysis, Workflow, IIBA, Organization, Chapter, Ecosystem

    With 30,000 members and 120 chapters worldwide, IIBA leads the global business analysis community and professional standards, shaping the practice of business analysis to achieve better enterprise outcomes.

    Key Points: 
    • With 30,000 members and 120 chapters worldwide, IIBA leads the global business analysis community and professional standards, shaping the practice of business analysis to achieve better enterprise outcomes.
    • Work on migrating IIBA chapters to the new platform began in February and will be completed in November 2024.
    • IIBA chapters are your global pass to analysis everywhere, as anyone in the world can attend a virtual chapter event to learn more about business analysis and its critical importance to organizations,” says Jared Gorai, Director, Chapters and Member Engagement at IIBA.
    • For more information on IIBA chapters or the chapter engagement platform, please contact IIBA Customer Support at [email protected] .

    GenSight Biologics Reports Cash Position as of March 31, 2024, and Provides Business Update

    Retrieved on: 
    木曜日, 4月 4, 2024
    Health, Neurology, Genetics, Pharmaceutical, Optical, Biotechnology, PIII, URD, Three-body problem, Patient, Good manufacturing practice, Health care, EAP, Acquisition, EMA, Risk, Chapter, GMP, MHRA, DS, ATU, AMF, Good, Phase, AAP, Ethics, FDA, Amendment, AAC, Medication, Pharmaceutical industry

    GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today reported its cash position as of March 31, 2024 and provided a business update.

    Key Points: 
    • GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today reported its cash position as of March 31, 2024 and provided a business update.
    • Once the AAC/AAP program resumes, the Company estimates that the cash runway would be extended to the end of Q1 2025.
    • GenSight successfully manufactured two Drug Substance (DS) batches of LUMEVOQ® meeting Good Manufacturing Practice (GMP) standards in September and November 2023.
    • As of March 31, 2024, GenSight Biologics’ number of outstanding shares was 78,370,724 ordinary shares.

    Analysis of Joint Venture Deals in Pharmaceuticals and Biotechnology Between 2016-2024 - ResearchAndMarkets.com

    Retrieved on: 
    月曜日, 4月 1, 2024
    Biotechnology, Pharmaceutical, Health, Chapter Three, Chapter Four, Chapter, Chapter One, A-Z, Orientation, Chapter Five, Chapter Six, Directory

    The "Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering.

    Key Points: 
    • The "Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering.
    • Joint Venture Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter joint venture deals.
    • Fully revised and updated, the report provides details of joint venture deals from 2016 to 2024.
    • Joint Venture Deals in Pharmaceuticals and Biotechnology includes:
      In Joint Venture Deals in Pharmaceuticals and Biotechnology, the available deals are listed by: